4//SEC Filing
Egan James 4
Accession 0001144204-11-026142
CIK 0001365216other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:43 PM ET
Size
5.4 KB
Accession
0001144204-11-026142
Insider Transaction Report
Form 4
Egan James
Chief Operating Officer
Transactions
- Award
Employee Stock Option (Right to buy)
2011-05-02+156,250→ 156,250 totalExercise: $4.41Exp: 2021-05-02→ Class A common stock (156,250 underlying)
Footnotes (1)
- [F1]Performance Conditions for vesting: 40% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $8/sh = 62,500; 40% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $12/sh = 62,500; and 20% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $16/sh = 31,250.
Documents
Issuer
Sucampo Pharmaceuticals, Inc.
CIK 0001365216
Entity typeother
Related Parties
1- filerCIK 0001296997
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 4:43 PM ET
- Size
- 5.4 KB